• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Corvex Reports Q1 2026 Financial Results and Provides Business Update

    5/19/26 4:06:00 PM ET
    $MOVE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $MOVE alert in real time by email

    Conference Call at 4:30 PM ET / 1:30 PM PT

    ARLINGTON, Va., May 19, 2026 /PRNewswire/ -- Corvex, Inc. (NASDAQ:MOVE), an engineering-led AI computing platform specializing in GPU-accelerated infrastructure for AI workloads, reported first quarter 2026 results and provided a business update.

    Corvex is an AI cloud computing company specializing in GPU-accelerated infrastructure for AI workloads. (PRNewsfoto/Corvex)

    Reported Q1'26 Highlights:

    • Completed acquisition of Corvex OpCo on March 19, 2026, transitioning the Company's primary business to AI cloud computing and renaming Movano Inc. to Corvex, Inc., effective March 23, 2026.
    • Including 12 days of Corvex OpCo operations in the period, Q1'26 total revenue was $510 thousand, compared to $206 thousand in Q1'25, including $475 thousand in AI Platform and services revenue contributed during the post-close stub period.
    • Deferred revenue, including current and non-current portions, grew to $4.4 million at March 31, 2026, from $12 thousand at December 31, 2025, reflecting contracted AI compute capacity not yet recognized.
    • Net loss of $(5.1) million, or $(3.13) per share, compared to a net loss of $(5.2) million, or $(5.35) per share, in Q1'25.
    • Adjusted EBITDA1 loss of $(1.6) million, improved by $3.3 million, or 67%, compared to $(4.9) million in Q1'25, reflecting disciplined execution as the Company concentrates resources on its AI platform opportunity.
    • The Company provided supplemental information, including pro forma consolidated financial data for the first quarter of 2026, including pro forma revenue of $3.7 million, pro forma net loss of $(15.9) million and pro forma adjusted EBITDA loss of $(0.9) million.
    • Cash and cash equivalents of $29.3 million at March 31, 2026.

    "The first quarter marked a defining moment for Corvex as we transitioned into the public markets. With our AI platform now operating as a public company, we believe Corvex is well-positioned to help define the next era of AI infrastructure. AI is reshaping the global computing landscape, and by combining scalable AI infrastructure, inference software, and confidential computing into a unified platform, we believe we are well-positioned to help AI-native organizations, enterprises, and government deploy and secure AI at an industrial scale," said Jay Crystal, Chief Executive Officer of Corvex.





















    1 See "Non-GAAP Financial Measures" and the reconciliation of GAAP to non-GAAP results table in this press release for additional information.

    First Quarter 2026 Financial Highlights



    Three Months Ended March 31,



    2026



    2025

    Revenue

    $                    510



    $                    206

    Operating expenses

    5,357



    5,444

    Loss from operations

    (4,847)



    (5,238)

    Other income (expense), net

    (158)



    60

    Net loss

    $                (5,005)



    $                (5,178)









    Cumulative dividends on Series A preferred stock

    (96)



    —

    Net loss attributable to common stockholders

    $                (5,101)



    $                (5,178)









    Net loss per share, basic and diluted

    $                  (3.13)



    $                  (5.35)









    Weighted average shares used in computing net loss per share, basic and

    diluted

    1,628,515



    967,331

    Conference Call

    Management will host a conference call and live audio webcast to discuss these results and provide a business update today at 4:30pm ET / 1:30pm PT. The live webcast of the earnings conference call can be accessed at the Corvex Investor Relations website at investors.corvex.ai. A replay of the webcast will be available at the same website.

    About Corvex

    Corvex is an AI cloud computing company specializing in GPU-accelerated infrastructure for AI workloads. Corvex's platform allows organizations to leverage the advantage of AI by providing secure, scalable, and cost-efficient computational resources. Corvex's infrastructure leverages advanced GPU-accelerated compute clusters, high-throughput storage systems and layered architecture to provide enhanced security, consistent performance, and efficiency at scale. As previously announced on March 19, 2026, Corvex, Inc. (formerly known as Movano Inc.) acquired Corvex Legacy Holdings, Inc. (Corvex OpCo, formerly known as Corvex, Inc.) (such acquisition the "Merger"). Following the Merger, the Company was renamed Corvex, Inc., effective March 23, 2026.

    Forward-Looking Statements

    This press release contains "forward-looking statements" within the meaning of applicable securities laws. Such statements are based on our current expectations, forecasts and assumptions and involve risks and uncertainties. These statements include, but are not limited to, statements related to our business; our strategy; our capital structure; our future growth; our technology; our projections for future active power; demand for our platform; other estimated amounts included in our revenue backlog figure; our plans to scale our platform and accelerate AI innovation; and strategic opportunities. In some cases, you can identify forward-looking statements by terms such as "anticipate," "believe," "estimate," "expect," "intend," "may," "might," "plan," "project," "will," "would," "should," "could," "can," "predict," "potential," "target," "explore," "continue," "outlook," "guidance," or the negative of these terms, where applicable, and similar expressions intended to identify forward-looking statements.

    Our expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected. These risks include but are not limited to our ability to execute our business strategies and manage our growth, our ability to maintain and grow our customer base, continued demand for AI infrastructure, any disruption in our strategic relationships or disruptions with our third-party providers, including our suppliers and data center partners, our ability to develop and maintain our corporate infrastructure and internal controls, our financial performance, capital requirements and ability to raise additional capital and the impact of global political and macroeconomic conditions, including the effects of global geopolitical conflicts, inflation, tariffs, interest rates, any instability in the global banking sector and foreign currency exchange rates. More information about factors that could affect our operating results is included under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our most recent filings with the SEC, including in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, copies of which may be obtained by visiting our Investor Relations website at investors.corvex.ai or the SEC's website at www.sec.gov. Forward-looking statements speak only as of the date the statements are made and are based on information available to us at the time those statements are made and/or management's good faith belief as of that time with respect to future events. We assume no obligation to update forward-looking statements to reflect events or circumstances after the date they were made, except as required by law. Our results for the fiscal quarter ended March 31, 2026 are not necessarily indicative of our operating results for any future periods.

    Non-GAAP Financial Measures

    To supplement our consolidated financial statements, which are prepared and presented in accordance with generally accepted accounting principles in the United States ("GAAP"), we use adjusted EBITDA to help us evaluate our business. We use this non-GAAP financial measure to make strategic decisions, establish business plans and forecasts, identify trends affecting our business, and evaluate operating performance. We believe that this non-GAAP financial measure may be helpful to investors because they allow for greater transparency into what measures we use in operating our business and measuring our performance and enable comparison of financial trends and results between periods where items may vary independent of business performance. This non-GAAP financial measure is presented for supplemental informational purposes only, should not be considered a substitute for financial information presented in accordance with GAAP, and may be different from similarly titled non-GAAP measures used by other companies.

    Adjusted EBITDA is defined as net loss, excluding (i) depreciation and amortization, (ii) stock-based compensation, (iii) transaction costs related to the Merger, (iv) Other expense (income), and (v) benefit from income taxes.

    A reconciliation is provided below to reconcile adjusted EBITDA to net loss, the most directly comparable financial measure stated in accordance with GAAP. Corvex encourages investors to review the related GAAP financial measure and the reconciliation of the non-GAAP financial measure to their most directly comparable GAAP financial measure, and not to rely on any single financial measure to evaluate Corvex's business.

    Summary Historical and Pro Forma Consolidated Financial Data

    To supplement our consolidated financial statements, we have also prepared the unaudited pro forma condensed combined financial information that is included below. This information has been prepared in accordance with Article 11 of Regulation S-X as amended by the final rule, Release No. 33-10786, "Amendments to Financial Disclosures about Acquired and Disposed Businesses." In the unaudited pro forma condensed combined financial information, the Merger has been accounted for as a business combination, using the acquisition method of accounting under U.S. GAAP, where the Company is considered to be the accounting acquirer and Corvex OpCo is the accounting acquiree. For more information on the unaudited pro forma condensed combined financial information, including the notes thereto, see Exhibit 99.1 to the Company's Current Report on Form 8-K, filed with the SEC on May 19, 2026.

    This unaudited pro forma condensed combined financial information is for informational purposes only and does not purport to indicate the financial conditions or results that would have been obtained had the Merger actually been completed on the assumed date or for the periods presented, nor what may be realized or expected in the future. The unaudited pro forma adjustments represent management's estimates based on information available as of the date of these unaudited pro forma condensed combined statements of operations and are subject to change as additional information becomes available and analyses are performed. The unaudited pro forma condensed combined statements of operations do not include any management adjustments related to the realization of any costs (or cost savings) from operating efficiencies or synergies. The unaudited condensed combined pro forma statements of operations are subject to certain risks and uncertainties that could cause actual results to differ materially from those illustrated.

    Media Contact

    Chris Donahoe, Stillpoint

    corvex.media@stillpointglobaladvisors.com

    CORVEX, INC.

    CONSOLIDATED STATEMENTS OF OPERATIONS

    (in thousands, except share and per share data) (unaudited)







    Three Months Ended

    March 31,







    2026





    2025



    REVENUE:













    Revenue - AI Platform and services



    $

    475





    $

    –



    Revenue - Connected devices and services





    35







    206



    Total revenue





    510







    206





















    OPERATING EXPENSES:

















    Cost of revenue - AI Platform and services (exclusive of depreciation and amortization)





    247







    –



    Cost of revenue - Connected devices and services (exclusive of depreciation and

    amortization)





    265







    642



    Depreciation and amortization





    326







    38



    Technology and infrastructure





    822







    2,364



    Sales and marketing





    304







    763



    General and administrative





    3,393







    1,637



    Total operating expenses





    5,357







    5,444





















    Loss from operations





    (4,847)







    (5,238)





















    Other (expense) income, net:

















    Interest expense (related party)





    (178)







    –



    Interest and other income, net





    20







    60



    Other (expense) income, net





    (158)







    60





















    Loss before provision for income taxes





    (5,005)







    (5,178)



    Income tax provision





    –







    –



    Net loss



    $

    (5,005)







    (5,178)





















    Cumulative dividends on Series A preferred stock



    $

    (96)





    $

    –



    Net loss attributable to common stockholders



    $

    (5,101)







    (5,178)





















    Net loss per share, basic and diluted



    $

    (3.13)





    $

    (5.35)





















    Weighted average shares used in computing net loss per share, basic and diluted





    1,628,515







    967,331



     

    CORVEX, INC.

    CONSOLIDATED BALANCE SHEETS

    (in thousands) (unaudited)







    March 31,

    2026





    December 31,

    2025



    ASSETS













    Current assets













    Cash and cash equivalents



    $

    29,330





    $

    2,827



    Accounts receivable, net





    1,504







    –



    Inventory





    1,776







    1,766



    Prepaid expenses and other current assets





    5,293







    394



    Total current assets





    37,903







    4,987



    Property and equipment, net





    29,074







    101



    Operating lease right-of-use assets, net





    3,792







    415



    Intangible assets, net





    15,359







    –



    Goodwill





    518,263







    –



    Other assets





    92







    97



    Total assets





    604,483







    5,600





















    LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

















    Current liabilities

















    Accounts payable





    3,668







    3,477



    Accrued liabilities





    1,535







    683



    Deferred revenue, current





    2,226







    12



    Bridge loan (related party)





    4,500







    4,382



    Operating lease liabilities, current





    1,893







    253



    Finance lease liabilities, current





    3,856







    –



    Total current liabilities





    17,678







    8,807



    Operating lease liabilities, non-current





    2,090







    267



    Finance lease liabilities, non-current





    6,559







    –



    Deferred revenue, non-current





    2,153







    –



    Total non-current liabilities





    10,802







    267



    Total liabilities





    28,480







    9,074





















    Commitments and contingencies (Note 13)



































    Stockholders' equity (deficit)

















    Preferred stock, $0.0001 par value, 5,000,000 shares authorized at March 31, 2026;

         56,639 and 3,000 shares issued and outstanding at March 31, 2026 and December 31,

         2025, respectively.





    574,469







    –



    Common stock, $0.0001 par value, 500,000,000 shares authorized at March 31, 2026 and

         December 31, 2025; 1,921,809 and 1,228,272 shares issued and outstanding at March

         31, 2026 and December 31, 2025, respectively





    –







    10



    Additional paid-in capital





    172,931







    162,908



    Accumulated deficit





    (171,397)







    (166,392)



    Total stockholders' equity (deficit)





    576,003







    (3,474)



    Total liabilities and stockholders' equity



    $

    604,483





    $

    5,600



     

    CORVEX, INC.

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    (in thousands) (unaudited)







    For the three months

    ended


    March 31,







    2026





    2025



    CASH FLOWS FROM OPERATING ACTIVITIES:













    Net loss



    $

    (5,005)





    $

    (5,178)



    Adjustments to reconcile net loss to net cash used in operating activities

















    Depreciation and amortization





    326







    38



    Stock-based compensation





    2,178







    299



    Noncash lease expense





    –







    8



    Write down of inventory to net realizable value





    32







    –



    Amortization of debt discount (related party)





    118







    –



    Changes in operating assets and liabilities, net of acquisition:

















    Accounts receivable





    (162)







    –



    Inventory





    (42)







    (212)



    Prepaid expenses and other current assets





    (747)







    142



    Other assets





    48







    (4)



    Accounts payable





    (1,362)







    509



    Deferred revenue





    27







    (18)



    Operating lease liabilities, net





    50







    –



    Accrued liabilities





    251







    113



    Net cash used in operating activities





    (4,288)







    (4,303)





















    CASH FLOWS FROM INVESTING ACTIVITIES:

















    Purchase of property and equipment





    (6,238)







    –



    Cash acquired in business combination





    36,679











    Net cash provided by investing activities





    30,441







    –





















    CASH FLOWS FROM FINANCING ACTIVITIES:

















    Payments on finance lease liabilities





    (32)







    –



    Issuance of common stock, net of issuance costs





    –







    758



    Issuance of common stock upon exercise of stock options





    382







    –



    Net cash provided by financing activities





    350







    758





















    Net increase (decrease) in cash and cash equivalents





    26,503







    (3,545)



    Cash and cash equivalents at beginning of period





    2,827







    7,902



    Cash and cash equivalents at end of period



    $

    29,330





    $

    4,357





















    SUPPLEMENTAL CASH FLOW INFORMATION:

















    Cash paid for interest



    $

    1





    $

    –



    Cash paid for taxes



    $

    –





    $

    –





















    NONCASH INVESTING AND FINANCING ACTIVITIES:

















    Issuance of common stock upon exercise of stock options in exchange for receivable



    $

    11





    $

    –



    Business acquired by issuance of equity instruments



    $

    581,911





    $

    –



    Broker receivable recorded in prepaid and other current assets for payroll withholding taxes



    $

    97





    $

    –



     

    Reconciliation of GAAP to Non-GAAP Results

    Reconciliation of Net Loss to Adjusted EBITDA

    (in thousands, except percentages)







    Three Months Ended

    March 31,





    Change









    2026





    2025





    $





    %





    Net loss



























    AI Platform and services



    $

    (1,625)





    $

    –





    $

    (1,625)







    (100)

    %



    Connected devices and services





    (3,380)







    (5,178)







    1,798







    35

    %



    Total net loss





    (5,005)







    (5,178)







    173







    3

    %







































    Adjusted EBITDA(1)



































    AI Platform and services





    (98)







    –







    (98)







    (100)

    %



    Connected devices and services





    (1,506)







    (4,901)







    3,395







    69

    %



    Total adjusted EBITDA



    $

    (1,604)





    $

    (4,901)





    $

    3,297







    67

    %







    (1)

    See the "Non-GAAP Financial Measures" section included above for a reconciliation to the most directly comparable GAAP measure.

     





    Three Months Ended

    March 31,



    AI Platform and services



    2026





    2025



    Net loss



    $

    (1,625)





    $

    –



    Depreciation and amortization





    295







    –



    Stock-based compensation(1)





    1,232







    –



    Transaction costs(2)





    –







    –



    Income tax





    –







    –



    Other expense (income), net





    –







    –



    Adjusted EBITDA



    $

    (98)





    $

    –



     





    Three Months Ended

    March 31,



    Connected devices and services



    2026





    2025



    Net loss



    $

    (3,380)





    $

    (5,178)



    Depreciation and amortization





    31







    38



    Stock-based compensation(1)





    946







    299



    Transaction costs(2)





    719







    –



    Income tax





    –







    –



    Other expense(income), net





    178







    (60)



    Adjusted EBITDA



    $

    (1,506)





    $

    (4,901)







    (1)

    Stock-based compensation: related to 2024 Equity Incentive Plan for employees, contractors, or other entities.

    (2)

    Related to the transaction costs associated with the merger.

     

    UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS

    FOR THE THREE MONTHS ENDED MARCH 31, 2026

    (in thousands, except share and per share data)





    Historical



    Total Pro Forma Adjustments

































    Corvex, Inc.





    Corvex Legacy

    Holdings, Inc.





    Transaction Accounting

    Adjustments: Merger

    Note 1



    Pro Forma

    Combined

























    Revenue

    $

    510



    $

    3,143



    $

    -



    $

    3,653

























    COSTS AND EXPENSES:























    Cost of revenue (exclusive of depreciation and amortization)



    512





    1,089





    592

    (b), (c)



    2,193

    Depreciation and amortization



    326





    1,671





    272

    (a)



    2,269

    Technology and infrastructure



    822





    274





    946

    (c), (d)



    2,042

    Sales and marketing



    304





    278





    263

    (c)



    845

    General and administrative



    3,393





    1,965





    6,316

    (b), (c),

    (d)



    11,674

    Total costs and expenses



    5,357





    5,277





    8,389





    19,023

























    Loss from operations



    (4,847)





    (2,134)





    (8,389)





    (15,370)

























    Other income (expense), net:























    Interest expense (related party)



    (178)





    -





    -





    (178)

    Interest and other income, net



    20





    (462)





    57

    (b)



    (385)

    Other income (expense), net



    (158)





    (462)





    57





    (563)

























    Net loss and total comprehensive loss

    $

    (5,005)



    $

    (2,596)



    $

    (8,332)



    $

    (15,933)

























    Net loss per share, basic and diluted

    $

    (3.13)









    $

    (4.08)



    $

    (7.81)

























    Weighted average shares used in computing net loss per

    share, basic and diluted



    1,628,515











    2,039,726





    2,039,726

     

    UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS

    FOR THE YEAR ENDED DECEMBER 31, 2025

    (in thousands, except share data)





    Historical



    Total Pro Forma Adjustments















































    Corvex,

    Inc.





    Corvex

    Legacy

    Holdings,

    Inc.





    Reclassification

    Adjustments

    Note 2



    Transaction

    Accounting

    Adjustments:

    Merger

    Note 2



    Total Pro

    Forma

    Adjustments





    Pro Forma

    Combined





































    Revenue

    $

    433



    $

    7,102



    $

    -



    $

    -



    $

    -



    $

    7,535





































    COSTS AND EXPENSES:



































    Cost of revenue (exclusive

    of depreciation and

    amortization)



    2,273





    2,851





    -





    2,744

    (e), (i)



    2,744





    7,868

    Depreciation and

    amortization



    -





    4,392





    149

    (a)



    1,061

    (b)



    1,210





    5,602

    Technology and

    infrastructure



    -





    1,342





    5,667

    (a)



    4,357

    (e), (f)



    10,024





    11,366

    Research and development



    5,740





    -





    (5,740)

    (a)



    -





    (5,740)





    -

    Sales and marketing



    -





    1,186





    1,410

    (a)



    1,213

    (e)



    2,623





    3,809

    General and administrative



    -





    7,099





    6,437

    (a)



    30,864

    (e), (f),

    (g), (h),

    (i)



    37,301





    44,400

    Sales, general and

    administrative



    7,923





    -





    (7,923)

    (a)



    -





    (7,923)





    -

    Total costs and

    expenses



    15,936





    16,870





    -





    40,239





    40,239





    73,045





































    Loss from operations (1)



    (15,503)





    (9,768)





    -





    (40,239)





    (40,239)





    (65,510)





































    Other income (expense), net:



































    Interest expense (related

    party)



    (2,965)





    -





    -





    -





    -





    (2,965)

    Loss (Gain) change in

    warrant liability fair value



    -





    (9,575)





    -





    9,575

    (c)



    9,575





    -

    Loss (Gain) in fair value of

    SAFE liability



    -





    9,856





    -





    (9,856)

    (d)



    (9,856)





    -

    Interest and other income,

    net



    183





    30





    -





    (77)

    (i)



    (77)





    136

    Other income

    (expense), net



    (2,782)





    311





    -





    (358)





    (358)





    (2,829)





































    Income tax benefits

    (expense)



    -





    (60)





    -





    -





    -





    (60)





































    Net loss and total

    comprehensive loss

    $

    (18,285)



    $

    (9,517)



    $

    -



    $

    (40,597)



    $

    (40,597)



    $

    (68,399)





































    Net loss per share, basic and

    diluted

    $

    (21.79)















    $

    (19.90)



    $

    (19.90)



    $

    (33.53)





































    Weighted average shares

    used in computing net loss

    per share, basic and diluted



    840,720

















    2,039,726





    2,039,726





    2,039,726

    Note 1 – Merger and Reclassification Transaction Adjustments to Unaudited Pro Forma Condensed Combined Statements of Operations for three months ended March 31, 2026

    (a)

    Reflects the estimated incremental amortization expense of $272 resulting from the Merger.







    Amortization expense related to the acquired finite-lived intangible assets has been calculated based on preliminary estimated fair values and estimated useful lives of 7 years for customer relationships and 20 years for trade names.







    The amount of amortization expense will ultimately be based on the periods in which the associated economic benefits are expected to be derived and the pattern of benefit for each intangible asset, and therefore, the preliminary amount reported may differ significantly between periods based upon the final values assigned to amortization methodology used for each asset.







    A 10% increase or decrease in the estimated fair value of the intangible assets would cause an increase or decrease of $27 to the amortization expense amounts as presented in the unaudited pro forma condensed combined statements of operations for the three months ended March 31, 2026.





    (b)

    Reflects decrease of lease expense in cost of revenue of $39, sales, general and administrative of $10 and interest expense of $57.





    (c)

    Reflects stock options post-combination expense of $631 to cost of revenue, $769 to technology and infrastructure, $263 to sales and marketing, and $2,955 to general and administrative.





    (d)

    Reflects restricted stock units post-combination expense of $177 in technology and infrastructure and $3,371 in general and administrative.

    Note 2 – Merger and Reclassification Transaction Adjustments to Unaudited Pro Forma Condensed Combined Statements of Operations for the year ended December 31, 2025

    (a)

    Represents the reclassification of sales, general and administrative expenses into sales and marketing and general and administrative expenses; the reclassification of research and development into technology and infrastructure; and the reclassification of historical Movano depreciation expense from research and development and sales, general and administrative expenses into depreciation expense. 





    (b)

    Reflects the estimated incremental amortization expense of $1,061 resulting from the Merger.







    A 10% increase or decrease in the estimated fair value of the intangible assets would cause an increase or decrease of $106 to the amortization expense amounts as presented in the unaudited pro forma condensed combined statements of operations for the year ended December 31, 2025.





    (c)

    Elimination of change in fair value of warrant liability as the Corvex Preferred Stock Warrants converted into shares of Corvex common stock and subsequently into Payment Shares, at the Exchange Ratio on the merger date.





    (d)

    Elimination of change in fair value of SAFE liability as the SAFEs automatically converted into shares of Corvex common stock and subsequently into Payment Shares, at the Exchange Ratio on the merger date.





    (e)

    Reflects stock options post-combination expense of $2,823 to cost of revenue, $3,540 to technology and infrastructure, $1,213 to sales and marketing, and $13,559 to general and administrative.





    (f)

    Reflects restricted stock units post-combination expense of $817 in technology and infrastructure and $15,526 in general and administrative.





    (g)

    Reflects estimated incremental transaction-related costs of approximately $719 incurred by the Company after December 31, 2025.





    (h)

    Reflects the accrual of severance payments pursuant to pre-existing employment agreements of $1,125.





    (i)

    Reflects decrease of lease expense in cost of revenue of $79, sales, general and administrative of $65 and interest expense of $77.

     

    Reconciliation of Unaudited Pro Forma GAAP to Non-GAAP Results

    Reconciliation of Net Loss to Adjusted EBITDA

    (in thousands, except percentages)











    Historical



    Pro Forma (i)









    Three Months Ended

    March 31,



    Year Ended

    December 31,



    Three Months Ended

    March 31,



    Year Ended

    December 31,

    Other financial

    information



    2026



    2025



    2026



    2025

    (in thousands of USD)

















    Net loss





    $

    (5,005)

    $

    (18,322)

    $

    (15,933)

    $

    (68,399)

    Depreciation and

    amortization



    326



    149



    2,269



    5,602

    Stock-based compensation



    2,178



    2,913



    10,344



    42,031

    Transaction costs (ii)





    719



    1,093



    1,824



    4,209

    Income tax





    -



    -



    -



    60

    Interest expense





    178



    2,782



    563



    2,829

    Adjusted EBITDA



    $

    (1,604)

    $

    (11,385)

    $

    (933)

    $

    (13,668)





    (i)

    Pro forma combined non-GAAP financial information is derived from the unaudited pro forma condensed combined statements of operations included within the unaudited pro forma condensed combined financial information contained elsewhere in this filing, which has been prepared in accordance with Article 11 of Regulation S-X.





    (ii)

    Transaction costs in the unaudited pro forma condensed combined statements of operations include transaction-related expenses arising from the Merger, as reflected in the transaction accounting adjustments within the unaudited pro forma condensed combined financial information. These amounts include both historical transaction expenses incurred prior to the closing of the Merger and additional expenses recognized in connection with the transaction.

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/corvex-reports-q1-2026-financial-results-and-provides-business-update-302776777.html

    SOURCE Corvex

    Get the next $MOVE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MOVE

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MOVE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Corvex Appoints AI Infrastructure Veteran Michael Craig as Vice President of Architecture and Site Operations

    Former Crusoe leader brings 25 years of experience across HPC architecture, GPU infrastructure, and site operationsARLINGTON, Va., July 15, 2026 /PRNewswire/ -- Corvex, Inc. (NASDAQ:MOVE), an engineering-led AI computing platform specializing in GPU-accelerated infrastructure for AI workloads, today announced the appointment of Michael Craig as Vice President of Architecture and Site Operations. Craig will lead cluster architecture and site operations for Corvex's AI Factory business, helping coordinate the technical, physical and supply-chain requirements necessary to convert high-density GPU infrastructure into reliable, prod

    7/15/26 9:00:00 AM ET
    $MOVE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Corvex Stockholders Approve Key Governance and Capital Structure Proposals at 2026 Annual Meeting

    Company Disposes of Legacy Movano Assets; Shareholders Elect Three New Directors; Approve Conversion of Series C and Series D Preferred Stock; Chance Moreland Joins as CFOARLINGTON, Va., July 1, 2026 /PRNewswire/ -- Corvex, Inc. (NASDAQ:MOVE), an engineering-led AI computing platform specializing in GPU-accelerated infrastructure for AI workloads, today announced the results of its 2026 Annual Meeting of Stockholders, held virtually. Shareholders voted to approve all proposals before them, including the election of three new directors to the Company's Board, authorization of the

    7/1/26 3:42:00 PM ET
    $MOVE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Finance and AI Executive Patrick Fleury to Join Corvex Board of Directors as Company Scales AI Cloud Infrastructure Platform and Prepares to Launch Token Factory

    TeraWulf CFO brings deep expertise across data center transactions, energy-advantaged digital infrastructure campuses, and large-scale capital formationARLINGTON, Va., June 26, 2026 /PRNewswire/ -- Corvex, Inc. (NASDAQ:MOVE), an engineering-led AI computing platform specializing in GPU-accelerated infrastructure for AI workloads, today announced the appointment of Patrick A. Fleury to its Board of Directors, upon election at the Company's upcoming annual meeting. Fleury currently serves as Chief Financial Officer of TeraWulf Inc. (NASDAQ:WULF), a publicly traded developer, owner

    6/26/26 9:00:00 AM ET
    $MOVE
    $WULF
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    EDP Services
    Technology

    $MOVE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-Chief Executive Officer Demsey Seth converted options into 5,515,658 shares, increasing direct ownership by 178% to 8,563,155 units (SEC Form 4)

    4 - Corvex, Inc. (0001734750) (Issuer)

    7/8/26 6:31:37 PM ET
    $MOVE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Co-Chief Executive Officer Crystal John Adler Iii converted options into 4,053,677 shares, increasing direct ownership by 109% to 6,414,723 units (SEC Form 4)

    4 - Corvex, Inc. (0001734750) (Issuer)

    7/8/26 6:31:04 PM ET
    $MOVE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Fairbairn Emily converted options into 1,205,282 shares (SEC Form 4)

    4 - Corvex, Inc. (0001734750) (Issuer)

    7/8/26 6:30:26 PM ET
    $MOVE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $MOVE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Caballero Ruben bought 22,000 shares, increasing direct ownership by 38% to 80,200 units (SEC Form 4)

    4 - Movano Inc. (0001734750) (Issuer)

    4/12/24 4:30:19 PM ET
    $MOVE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Fairbairn Emily bought 4,690,000 shares (SEC Form 4)

    4 - Movano Inc. (0001734750) (Issuer)

    4/4/24 5:30:08 PM ET
    $MOVE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Cogan Jeremy bought 45,000 shares, increasing direct ownership by 6% to 780,649 units (SEC Form 4)

    4 - Movano Inc. (0001734750) (Issuer)

    4/4/24 5:30:14 PM ET
    $MOVE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $MOVE
    SEC Filings

    View All

    SEC Form S-1 filed by Corvex Inc.

    S-1 - Corvex, Inc. (0001734750) (Filer)

    7/10/26 5:10:53 PM ET
    $MOVE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Corvex Inc. filed SEC Form 8-K: Other Events, Unregistered Sales of Equity Securities, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - Corvex, Inc. (0001734750) (Filer)

    7/7/26 5:10:57 PM ET
    $MOVE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form S-8 filed by Corvex Inc.

    S-8 - Corvex, Inc. (0001734750) (Filer)

    7/1/26 4:58:37 PM ET
    $MOVE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $MOVE
    Financials

    Live finance-specific insights

    View All

    Corvex Reports Q1 2026 Financial Results and Provides Business Update

    Conference Call at 4:30 PM ET / 1:30 PM PTARLINGTON, Va., May 19, 2026 /PRNewswire/ -- Corvex, Inc. (NASDAQ:MOVE), an engineering-led AI computing platform specializing in GPU-accelerated infrastructure for AI workloads, reported first quarter 2026 results and provided a business update. Reported Q1'26 Highlights:Completed acquisition of Corvex OpCo on March 19, 2026, transitioning the Company's primary business to AI cloud computing and renaming Movano Inc. to Corvex, Inc., effective March 23, 2026.Including 12 days of Corvex OpCo operations in the period, Q1'26 total revenue w

    5/19/26 4:06:00 PM ET
    $MOVE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Corvex to Host First Quarter 2026 Earnings Call on Tuesday, May 19, 2026

    Conference Call at 4:30 PM ET/ 1:30 PM PTARLINGTON, Va., May 11, 2026 /PRNewswire/ -- Corvex, Inc. (NASDAQ:MOVE), an engineering-led AI computing platform specializing in GPU-accelerated infrastructure for AI workloads, today announced that it will hold its first quarter 2026 earnings call on Tuesday, May 19, 2026 at 4:30 pm ET / 1:30 pm PT. Management will host a conference call and live audio webcast to discuss first quarter 2026 results and provide a business update. The live webcast of the earnings conference call can be accessed at the Corvex Investor Relations website at i

    5/11/26 8:30:00 AM ET
    $MOVE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    CORVEX, INC. ANNOUNCES ADDITIONAL DETAILS OF SPECIAL 35.8% STOCK DIVIDEND FOR SHAREHOLDERS OF RECORD ON MARCH 30, 2026

    ARLINGTON, Va., March 24, 2026 /PRNewswire/ -- Corvex, Inc. (NASDAQ:MOVE) ("Corvex" or the "Company") today announced additional details regarding the special 35.8% stock dividend (the "Stock Dividend") previously announced on March 19, 2026.  Each stockholder of record as of the close of business on March 30, 2026 will be entitled to receive a 35.8% stock dividend at no cost and with no action required on the part of the stockholder.For example, a stockholder holding 10,000 shares of Corvex common stock, par value $0.0001 per share (the "Common Stock") as of the close of tradin

    3/24/26 8:00:00 AM ET
    $MOVE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $MOVE
    Leadership Updates

    Live Leadership Updates

    View All

    Corvex Appoints AI Infrastructure Veteran Michael Craig as Vice President of Architecture and Site Operations

    Former Crusoe leader brings 25 years of experience across HPC architecture, GPU infrastructure, and site operationsARLINGTON, Va., July 15, 2026 /PRNewswire/ -- Corvex, Inc. (NASDAQ:MOVE), an engineering-led AI computing platform specializing in GPU-accelerated infrastructure for AI workloads, today announced the appointment of Michael Craig as Vice President of Architecture and Site Operations. Craig will lead cluster architecture and site operations for Corvex's AI Factory business, helping coordinate the technical, physical and supply-chain requirements necessary to convert high-density GPU infrastructure into reliable, prod

    7/15/26 9:00:00 AM ET
    $MOVE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Corvex Stockholders Approve Key Governance and Capital Structure Proposals at 2026 Annual Meeting

    Company Disposes of Legacy Movano Assets; Shareholders Elect Three New Directors; Approve Conversion of Series C and Series D Preferred Stock; Chance Moreland Joins as CFOARLINGTON, Va., July 1, 2026 /PRNewswire/ -- Corvex, Inc. (NASDAQ:MOVE), an engineering-led AI computing platform specializing in GPU-accelerated infrastructure for AI workloads, today announced the results of its 2026 Annual Meeting of Stockholders, held virtually. Shareholders voted to approve all proposals before them, including the election of three new directors to the Company's Board, authorization of the

    7/1/26 3:42:00 PM ET
    $MOVE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Finance and AI Executive Patrick Fleury to Join Corvex Board of Directors as Company Scales AI Cloud Infrastructure Platform and Prepares to Launch Token Factory

    TeraWulf CFO brings deep expertise across data center transactions, energy-advantaged digital infrastructure campuses, and large-scale capital formationARLINGTON, Va., June 26, 2026 /PRNewswire/ -- Corvex, Inc. (NASDAQ:MOVE), an engineering-led AI computing platform specializing in GPU-accelerated infrastructure for AI workloads, today announced the appointment of Patrick A. Fleury to its Board of Directors, upon election at the Company's upcoming annual meeting. Fleury currently serves as Chief Financial Officer of TeraWulf Inc. (NASDAQ:WULF), a publicly traded developer, owner

    6/26/26 9:00:00 AM ET
    $MOVE
    $WULF
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    EDP Services
    Technology

    $MOVE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Movano Inc.

    SC 13G - Movano Inc. (0001734750) (Subject)

    4/10/24 4:39:12 PM ET
    $MOVE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G/A filed by Movano Inc. (Amendment)

    SC 13G/A - Movano Inc. (0001734750) (Subject)

    4/9/24 5:41:12 PM ET
    $MOVE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G filed by Movano Inc.

    SC 13G - Movano Inc. (0001734750) (Subject)

    2/4/22 4:20:05 PM ET
    $MOVE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care